539 related articles for article (PubMed ID: 31209778)
1. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
2. Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Leithner D; Horvat JV; Marino MA; Bernard-Davila B; Jochelson MS; Ochoa-Albiztegui RE; Martinez DF; Morris EA; Thakur S; Pinker K
Breast Cancer Res; 2019 Sep; 21(1):106. PubMed ID: 31514736
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results.
Marino MA; Pinker K; Leithner D; Sung J; Avendano D; Morris EA; Jochelson M
Mol Imaging Biol; 2020 Jun; 22(3):780-787. PubMed ID: 31463822
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the clinicopathological subtypes of breast cancer using a fisher discriminant analysis model based on radiomic features of diffusion-weighted MRI.
Ni M; Zhou X; Liu J; Yu H; Gao Y; Zhang X; Li Z
BMC Cancer; 2020 Nov; 20(1):1073. PubMed ID: 33167903
[TBL] [Abstract][Full Text] [Related]
6. Support vector machine for breast cancer classification using diffusion-weighted MRI histogram features: Preliminary study.
Vidić I; Egnell L; Jerome NP; Teruel JR; Sjøbakk TE; Østlie A; Fjøsne HE; Bathen TF; Goa PE
J Magn Reson Imaging; 2018 May; 47(5):1205-1216. PubMed ID: 29044896
[TBL] [Abstract][Full Text] [Related]
7. Histogram Analysis and Visual Heterogeneity of Diffusion-Weighted Imaging with Apparent Diffusion Coefficient Mapping in the Prediction of Molecular Subtypes of Invasive Breast Cancers.
Horvat JV; Iyer A; Morris EA; Apte A; Bernard-Davila B; Martinez DF; Leithner D; Sutton OM; Ochoa-Albiztegui RE; Giri D; Pinker K; Thakur SB
Contrast Media Mol Imaging; 2019; 2019():2972189. PubMed ID: 31819738
[TBL] [Abstract][Full Text] [Related]
8. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
Bickelhaupt S; Paech D; Kickingereder P; Steudle F; Lederer W; Daniel H; Götz M; Gählert N; Tichy D; Wiesenfarth M; Laun FB; Maier-Hein KH; Schlemmer HP; Bonekamp D
J Magn Reson Imaging; 2017 Aug; 46(2):604-616. PubMed ID: 28152264
[TBL] [Abstract][Full Text] [Related]
9. Radiomic analysis on magnetic resonance diffusion weighted image in distinguishing triple-negative breast cancer from other subtypes: a feasibility study.
Wang Q; Mao N; Liu M; Shi Y; Ma H; Dong J; Zhang X; Duan S; Wang B; Xie H
Clin Imaging; 2021 Apr; 72():136-141. PubMed ID: 33242692
[TBL] [Abstract][Full Text] [Related]
10. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
11. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
[TBL] [Abstract][Full Text] [Related]
12. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
[TBL] [Abstract][Full Text] [Related]
13. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
[TBL] [Abstract][Full Text] [Related]
14. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
[TBL] [Abstract][Full Text] [Related]
15. Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics.
Leithner D; Mayerhoefer ME; Martinez DF; Jochelson MS; Morris EA; Thakur SB; Pinker K
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545851
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Background Parenchymal Enhancement and Histogram-Based Diffusion-Weighted Image in Determining the Molecular Subtype of Breast Cancer.
You C; Zhang Y; Chen Y; Hu X; Hu D; Wu J; Gu Y; Peng W
J Comput Assist Tomogr; 2021 Sep-Oct 01; 45(5):711-716. PubMed ID: 34546678
[TBL] [Abstract][Full Text] [Related]
17. The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images.
Yuen S; Monzawa S; Yanai S; Matsumoto H; Yata Y; Ichinose Y; Deai T; Hashimoto T; Tashiro T; Yamagami K
Breast Cancer; 2020 Sep; 27(5):1029-1037. PubMed ID: 32377938
[TBL] [Abstract][Full Text] [Related]
18. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J
Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958
[TBL] [Abstract][Full Text] [Related]
19. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
Xie T; Zhao Q; Fu C; Bai Q; Zhou X; Li L; Grimm R; Liu L; Gu Y; Peng W
Eur Radiol; 2019 May; 29(5):2535-2544. PubMed ID: 30402704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
